Published in Antimicrob Agents Chemother on October 01, 1985
Pharmacokinetics of intravenously administered cefmetazole and cefoxitin and effects of probenecid on cefmetazole elimination. Antimicrob Agents Chemother (1989) 1.13
Biliary excretion and choleretic effect of cefmetazole in rats. Antimicrob Agents Chemother (1989) 0.82
Pharmacokinetics and dose proportionality of cefmetazole in healthy young and elderly volunteers. Antimicrob Agents Chemother (1990) 0.82
Pharmacokinetics of intravenous cefmetazole with emphasis on comparison between predicted theoretical levels in tissue and actual skin window fluid levels. Antimicrob Agents Chemother (1989) 0.76
Pharmacokinetics of single-dose cefmetazole following intramuscular administration of cefmetazole sodium to healthy male volunteers. Antimicrob Agents Chemother (1989) 0.76
Disposition of cefmetazole in healthy volunteers and patients with impaired renal function. Antimicrob Agents Chemother (1990) 0.75
Pharmacokinetics and clinical use of cephalosporin antibiotics. J Pharm Sci (1975) 4.01
A new semisynthetic 7alpha-methoxycephalosporin, CS-1170: 7beta-((cyanomethyl)thio)acetamido)-7alpha-methoxy-3-((1-methyl-1H-tetrazol-5-yl)thio)methyl)-3-cephem-4-carboxylic acid. J Antibiot (Tokyo) (1976) 2.48
ESTRIP, a BASIC computer program for obtaining initial polyexponential parameter estimates. J Pharm Sci (1978) 2.33
Multiple intravenous dose pharmacokinetics of ceftriaxone in man. Chemotherapy (1981) 1.96
In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibiotic. Antimicrob Agents Chemother (1982) 1.87
High-performance liquid chromatographic method for determination of cefmetazole in human serum. Antimicrob Agents Chemother (1982) 1.21
Pharmacokinetics of cefmetazole in normal subjects and in patients with impaired renal function. Antimicrob Agents Chemother (1980) 1.20
Pharmacokinetics of cefamandole using a HPLC assay. J Pharmacokinet Biopharm (1978) 1.15
Concentrations of cefmetazole in plasma and tissue resulting from peri-incisional administration before appendectomy. Antimicrob Agents Chemother (1984) 1.02
Pharmacokinetics of cefotiam administered intravenously and intramuscularly to healthy adults. Antimicrob Agents Chemother (1984) 0.98
Ceftizoxime kinetics and renal handling. Clin Pharmacol Ther (1982) 0.89
Influence of dosage form and administration route on the pharmacokinetic parameters of cefadroxil. Int J Clin Pharmacol Ther Toxicol (1982) 0.85
Pharmacokinetics of cefoxitin in patients with normal or impaired renal function. Eur J Clin Pharmacol (1979) 0.84
Concentrations of cefmetazole in plasma and tissue resulting from peri-incisional administration before appendectomy. Antimicrob Agents Chemother (1984) 1.02
Population pharmacokinetics of amikacin in patients with haematological malignancies. J Antimicrob Chemother (1999) 0.94
The influence of uremia on the accessibility of phosphomycin into interstitial tissue fluid. Eur J Clin Pharmacol (1983) 0.92
Monitoring of serum levels of imipramine and desipramine and individualization of dose in enuretic children. Ther Drug Monit (1984) 0.86
Influence of dosage form and administration route on the pharmacokinetic parameters of cefadroxil. Int J Clin Pharmacol Ther Toxicol (1982) 0.85
A comparative in vitro study of percutaneous penetration of beta-blockers in human skin. Int J Pharm (2000) 0.85
Pharmacokinetics of cefoxitin in patients with normal or impaired renal function. Eur J Clin Pharmacol (1979) 0.84
Pharmacokinetics of cefoxitin in patients undergoing hemodialysis. Int J Clin Pharmacol Biopharm (1979) 0.84
Stability of an oral midazolam solution for premedication in paediatric patients. Pharm World Sci (1994) 0.83
Pharmacokinetics of cephacetrile in patients undergoing haemodialysis. Eur J Clin Pharmacol (1979) 0.82
Pleural fluid levels of cefoxitin in patients with renal impairment. Int J Clin Pharmacol Ther Toxicol (1986) 0.82
Pharmacokinetics of cefoxitin during haemofiltration. Eur J Clin Pharmacol (1983) 0.82
Pharmacokinetics of cefamandole in patients undergoing hemodialysis. Int J Clin Pharmacol Biopharm (1979) 0.82
Linearity of the pharmacokinetics of phosphomycin in serum and interstitial tissue fluid in rabbits. Arzneimittelforschung (1986) 0.81
Kinetics of ketamine and its metabolites in rabbits with normal and impaired renal function. Eur J Drug Metab Pharmacokinet (1985) 0.81
Population pharmacokinetics of caffeine in premature neonates. Eur J Clin Pharmacol (1997) 0.81
Disposition of cefoxitin in patients with pleural effusion. Clin Ther (1981) 0.81
Influence of pharmacokinetic model on vancomycin peak concentration targets. Ther Drug Monit (1996) 0.81
Pharmacokinetics of amoxapine and its active metabolites. Int J Clin Pharmacol Ther Toxicol (1985) 0.81
Influence of dose in the urinary excretion of amikacin. Int J Clin Pharmacol Ther Toxicol (1984) 0.80
Error structure for the HPLC analysis for atenolol, metoprolol and propranolol: a useful weighting method in parameter estimation. J Pharm Biomed Anal (1998) 0.80
Disposition of phosphomycin in patients with pleural effusion. Antimicrob Agents Chemother (1984) 0.80
Influence of dose on the pharmacokinetics of cefadroxil. Eur J Clin Pharmacol (1980) 0.79
Disposition of cefoxitin in the elderly. Int J Clin Pharmacol Ther Toxicol (1980) 0.79
Comparison of methods of carbamazepine dosage, individualization in epileptic patients. J Clin Pharm Ther (1988) 0.79
Pharmacokinetics of ricobendazole in calves. J Vet Pharmacol Ther (2001) 0.78
Pharmacokinetics of amoxycillin in normal horses and horses with experimental arthritis. J Vet Pharmacol Ther (2001) 0.78
Disposition of cefoxitin in patients with ascites. Eur J Clin Pharmacol (1981) 0.78
Non-linear tissue binding of amikacin in rats: the effect of renal impairment. Eur J Drug Metab Pharmacokinet (1988) 0.77
Pharmacokinetics of amikacin in intensive care unit patients. J Clin Pharm Ther (1996) 0.77
Modification in the pharmacokinetics of amikacin during development. Eur J Clin Pharmacol (1982) 0.77
Predictive performance of two phenytoin pharmacokinetic dosing programs from nonsteady state data. Ther Drug Monit (1994) 0.77
Individualization of theophylline dosage in adults with bronchial asthma. Drug Intell Clin Pharm (1986) 0.76
Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications. Bone Marrow Transplant (1997) 0.76
Pharmacokinetics of cefazolin administered as a new drug delivery system in healthy volunteers. Biopharm Drug Dispos (1989) 0.76
The pharmacokinetics of cefadroxil associated with probenecid. Int J Clin Pharmacol Ther Toxicol (1981) 0.76
Pharmacokinetics of amikacin in children with normal and impaired renal function. Kidney Int (1981) 0.76
Effect of experimentally induced renal impairment on the pharmacokinetics of cefadroxil in rabbits. Arzneimittelforschung (1981) 0.75
Pharmacokinetics, hepatic biotransformation and biliary and urinary excretion of bromosulfophthalein (BSP) in an experimental liver disease mimicking biliary cirrhosis. Eur J Drug Metab Pharmacokinet (1990) 0.75
Pharmacokinetics of phosphomycin during haemofiltration. Br J Clin Pharmacol (1984) 0.75
Pharmacokinetics of sodium and trihydrate amoxicillin in sheep after intravenous and intramuscular administration. J Vet Pharmacol Ther (2007) 0.75
The influence of ascites on the pharmacokinetics of amikacin. Int J Clin Pharmacol Ther Toxicol (1980) 0.75
Phosphomycin levels in serum and interstitial tissue fluid in a multiple dosage regimen in rabbits. Arzneimittelforschung (1987) 0.75
Determination of bentazepam in plasma by high-performance liquid chromatography. J Pharm Biomed Anal (1987) 0.75
Two reproducible and sensitive liquid chromatographic methods to quantify atenolol and propranolol in human plasma and determination of their associated analytical error functions. J Chromatogr B Biomed Sci Appl (2000) 0.75
[Protein binding of sulphachlorpiridacine (author's transl)]. Arch Farmacol Toxicol (1979) 0.75
TDM of theophylline--compliance evaluation. J Clin Pharm Ther (1988) 0.75
[Serum levels and spirometric response with sustained release theophylline]. Med Clin (Barc) (1985) 0.75
Pharmacokinetic parameters from data relating to the plasma and biliary excretion kinetics of cefmetazole in rats. Eur J Drug Metab Pharmacokinet (1993) 0.75
Disposition and excretion of cefoperazone in rabbits. Arzneimittelforschung (1987) 0.75
Comparative study of different weighting methods in non-linear regression analysis: implications in the parametrization of carebastine after intravenous administration in healthy volunteers. Int J Clin Pharmacol Ther (1998) 0.75
Effect of dose on the kinetic behaviour of valproic acid: modifications in plasma protein binding. Eur J Drug Metab Pharmacokinet (1991) 0.75
[Serum levels, dose and response in prolonged treatment with theophylline]. Med Clin (Barc) (1984) 0.75
High pressure liquid chromatographic method for the analysis of isonixine in plasma. Farmaco Prat (1983) 0.75
[Stabilization of procaine hydrochloride with methylidene, glycerin and 1,2-propyleneglycol. 3]. Farmaco Prat (1971) 0.75
Evaluation of thermodynamic ionization constants by computation of spectrophotometric and potentiometric experimental data obtained simultaneously from a flow system. J Pharm Sci (1992) 0.75
Multicriteria decision analysis for determining drug therapy for intermittent claudication. Methods Find Exp Clin Pharmacol (1998) 0.75
Pharmacokinetics of cefotiam during hemofiltration. Int J Clin Pharmacol Ther Toxicol (1986) 0.75
[Quantitative analysis of vitamins B1, B6 and B12 in tablets by thin layer chromatography]. Farmaco Prat (1972) 0.75
Determination of analytical error function for beta-blockers as a possible weighting method for the estimation of the regression parameters. J Pharm Biomed Anal (1996) 0.75
Disposition of cefadroxil administered orally to rabbits with experimentally induced renal impairment. Arzneimittelforschung (1981) 0.75
Bioequivalence of a new formulation of flecainide acetate. Eur J Drug Metab Pharmacokinet (1991) 0.75
Influence of hepatic and renal disorders on the pharmacokinetics of sulfachloropyridacine. Int J Clin Pharmacol Ther Toxicol (1980) 0.75
Study of the disposition kinetics of the N-oxide-derivative: a metabolite of picobenzide. Eur J Drug Metab Pharmacokinet (1989) 0.75
Influence of experimentally induced cholestasis on the pharmacokinetics of cefotiam. Arzneimittelforschung (1984) 0.75
Open-loop feedback control of serum bentazepam concentrations and Bayesian estimation in multiple dosage regimens in patients. Int J Clin Pharmacol Ther Toxicol (1991) 0.75
Discrimination of kinetic models in heteroscedastic parametric estimation of bentazepam following multiple dosing. Int J Clin Pharmacol Ther Toxicol (1988) 0.75
[Determination of procaine hydrochloride with butanediols. II]. Farmaco Prat (1971) 0.75
[Muscular toxicity of polyols. IV]. Farmaco Prat (1971) 0.75
Binding of theophylline, ethophylline and diprophylline to human serum albumin. Farmaco Prat (1989) 0.75
Influence of partial hepatectomy in rats on the activity of hepatic microsomal enzymatic systems. Eur J Drug Metab Pharmacokinet (1997) 0.75
Cefmetazole plasma levels after intraincisional administration. Drug Intell Clin Pharm (1985) 0.75
Distribution of cephalothin and ceftriaxone into experimental interstitial tissue fluid in rabbits. Arzneimittelforschung (1986) 0.75
The effects of the method of calculation on the evaluation of the pharmacokinetic parameters of oxytetracycline after intravenous administration to calves. Vet Res Commun (1997) 0.75
[Polyols-pharmaceutical and toxicological characteristics. I]. Farmaco Prat (1971) 0.75
Comparison of two methods in the estimation of the pharmacokinetic parameters of phenytoin. J Clin Pharm Ther (1990) 0.75
Pharmacokinetics of amikacin (BB-K8) in patients undergoing hemodialysis. Int J Clin Pharmacol Biopharm (1979) 0.75
Drug dosage in end-stage renal disease (ESRD) patients undergoing haemodialysis. A predictive study based on a microcomputer program. Clin Pharmacokinet (1993) 0.75
Quantitative determination of ketamine and its metabolites in man by gas-liquid chromatography. Farmaco Prat (1983) 0.75
Application of population pharmacokinetics to the optimization of theophylline therapy. J Clin Pharm Ther (1996) 0.75
Determination of N-oxide of picobenzide by differential pulse polarography. Farmaco Prat (1983) 0.75
Pharmacokinetics and distribution of ketamine after extradural administration to dogs. Br J Anaesth (1991) 0.75
Pharmacokinetics of tiadipone: a new anxiolytic. Int J Clin Pharmacol Ther Toxicol (1986) 0.75
Multiple dose pharmacokinetics of a new cefazolin derivative for sustained release. J Antimicrob Chemother (1989) 0.75
A discriminatory study of a pharmacokinetic model for intramuscular gentamicin in sheep. Vet Res Commun (1990) 0.75
[Pharmacokinetics of sulfachlorpyridazine]. Arch Farmacol Toxicol (1979) 0.75
[Individualized dosage of theophylline for ambulatory asthmatic patients]. Med Clin (Barc) (1983) 0.75
Determination of celiprolol and oxprenolol in human plasma by high-performance liquid chromatography and the analytical error function. J Chromatogr B Biomed Sci Appl (1998) 0.75
[Biopharmaceutical study of the association of colloidal N-butyl bromide of scopolamine and sodium lauryl sulfate. I]. Farmaco Prat (1974) 0.75
Minimizing digoxin-like immunoreactivity with TDx digoxin in dialysis patients. Ther Drug Monit (1997) 0.75